Latest Asx Listing News

C29 Metals has explained a delayed filing of a director interest notice as an isolated administrative oversight, reaffirming its compliance policies.

Klevo Rewards Limited has been granted a crucial extension by the ASX, postponing its automatic removal from the official list until 6 January 2026 as it works to meet reinstatement conditions.

Findi Limited reported a 51% surge in revenue to $49.26 million for the half year ended 30 September 2025, driven by key acquisitions in India. However, the company posted a significant operating loss of $24.65 million amid integration costs and faces material uncertainty over its going concern status.

Activeport Group Ltd has revised the timetable for its pro-rata bonus issue of unquoted options, outlining key dates and eligible shareholders across multiple countries.

Cauldron Energy’s CEO posted a video during a trading halt that prematurely hinted at exploration results, breaching ASX disclosure rules. The company acknowledges the misstep and outlines steps to tighten compliance.

Meteoric Resources NL has voluntarily suspended trading of its shares on the ASX pending a key announcement addressing media speculation about its Preliminary License approval process.

Galilee Energy has voluntarily suspended its shares from trading as it finalises a significant capital raising and acquisition, with an announcement expected by 1 December 2025.

Vinyl Group Ltd has reported a striking 190% revenue increase in FY25, driven by strategic acquisitions and organic growth, and is targeting its first profitable quarter by December 2025 with AI-powered publishing expansion.

Prime Financial Group has reported robust FY25 results, doubling its revenue run rate and expanding its high-net-worth client base through strategic acquisitions. The company sets ambitious growth targets for FY26 and beyond, underpinned by technology investments and leadership enhancements.

Pathkey.AI has secured A$2.5 million through a placement and launched a nearly A$1 million rights issue to fund expansion of its AI-driven TrialKey platform and pursue strategic acquisitions, alongside key board changes.

Ironbark Capital reported an 8.4% portfolio return for FY25 and announced plans to rebrand and introduce quarterly dividends to address its persistent discount to net tangible assets.

Race Oncology has received a $2.8 million Australian R&D tax refund for FY2025, with further overseas R&D rebates expected, bolstering its clinical development of innovative cancer therapies.